(Q34192375)

31 July 2017

1 reference

title

The mouse light-dark paradigm: a review (English)

1 reference

31 July 2017

Hascoët M

1

1 reference

31 July 2017

Bourin M

series ordinal

2

1 reference

31 July 2017

Nic Dhonnchadha BA

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

31 July 2017

published in

1 reference

31 July 2017

volume

25

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

141-166

1 reference

Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Ketotifen and its analogues reduce aversive responding in the rodent

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

A schematic representation of the psychopharmacological profile of antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Anxiolytic effects of CCK-B antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Exploration of mice in a black and white test box: validation as a model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Actions of buspirone in a putative model of anxiety in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Exploratory behavior models of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Effects of acute and subchronic administration of ritanserin on the social behaviour of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Preclinical profile of the mixed 5-HT1A/5-HT2A receptor antagonist S 21,357.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

5-Hydroxytryptamine pathways in anxiety and its treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

A new approach to the light/dark test procedure in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Influence of Age on Behavioural Response in the Light/Dark Paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

1 reference

7 January 2021

Anxiolytic-like effect of paroxetine in a rat social interaction test

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Ethologically-based animal models of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Anxiolytic and sedative effects of 5-HT1A ligands, 8-OH-DPAT and MDL 73005EF, in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Relationship between memory and fear: developmental and pharmacological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Anxiolytic action of CGS 9896 on mouse exploratory behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Cholecystokinin in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

A fully automated light/dark apparatus useful for comparing anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900151-2

7 January 2021

10.1016/S0278-5846(00)00151-2

Identifiers

DOI

1 reference

31 July 2017

1 reference